Puerarin improves graft bone defect through microRNA-155-3p-mediated p53/TNF-α/STAT1 signaling pathway

Bone graft defects may lead to dysfunction of bone regeneration and metabolic disorders of bone mesenchymal stem cells (BMSCs). Puerarin has demonstrated pharmacological activities in the treatment of human metabolic diseases. The purpose of the present study was to investigate the role of puerarin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yang, Lian, Hongyu, Liu, Kexin, Wang, Deli, Xiu, Xuelian, Sun, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255454/
https://www.ncbi.nlm.nih.gov/pubmed/32377717
http://dx.doi.org/10.3892/ijmm.2020.4595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255454/
https://www.ncbi.nlm.nih.gov/pubmed/32377717
http://dx.doi.org/10.3892/ijmm.2020.4595

Ejemplares similares